The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic

Data were predominantly analysed descriptively; chi-squared and Fisher's exact tests were conducted to compare changes to treatment and monitoring due to COVID-19 between age groups, sex and diagnosis (NMIBC/MIBC). Fisher's exact tests did not reveal significant differences in treatment di...

Full description

Saved in:
Bibliographic Details
Published in:BJUI compass 2022-09, Vol.3 (5), p.324-326
Main Authors: Russell, Beth, Spencer‐Bowdage, Sarah, Rigby, Jeannie, O'Kelly, Jackie, Kelly, Phil, Page, Mark, Raw, Caroline, Allchorne, Paula, Harper, Peter, Crew, Jeremy, Kockelbergh, Roger, Knight, Allen, Van Hemelrijck, Mieke, Bryan, Richard T.
Format: Article
Language:English
Subjects:
Age groups
Bladder cancer
Cancer therapies
COVID-19
Pandemics
patient experience
Patients
Research Communication
survey
To the Point
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Data were predominantly analysed descriptively; chi-squared and Fisher's exact tests were conducted to compare changes to treatment and monitoring due to COVID-19 between age groups, sex and diagnosis (NMIBC/MIBC). Fisher's exact tests did not reveal significant differences in treatment disruption between age groups, sex and NMIBC/MIBC. [...]for patients undergoing monitoring/follow-up, statistically significant differences were observed for age groups (p = 0.020) and NMIBC/MIBC (p = 0.006)—a higher proportion of younger patients were not scheduled for monitoring (older patients mostly reported that their monitoring occurred as expected), and more patients with NMIBC had their monitoring appointment postponed or cancelled (n = 17) compared with MIBC patients (n = 1).
ISSN:2688-4526
2688-4526
DOI:10.1002/bco2.153